PTH and osteoporosis: Teriparatide, a recombinant form of human parathyroid hormone, acts as an osteoanabolic agent, increasing BMD and reducing the incidence of fragility fractures in postmenopausal women and cases of glucocorticoid-induced osteoporosis.